Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that
has caused the recent coronavirus disease (COVID-19) global pandemic. The current …

Background Older adults are more susceptible to severe health outcomes for coronavirus
disease 2019 (COVID-19). Universal vaccination has become a trend, but there are still …

Although numerous clinical trials have been implemented, an absolutely effective treatment
against coronavirus disease 2019 (COVID-19) is still elusive. Interleukin-22 (IL-22) has …

At the end of 2019, the world began to fight the coronavirus disease 2019 (COVID-19)
pandemic caused by the severe acute respiratory syndrome coronavirus-2. Many vaccines …

The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …

Due to the wide scope and persistence of COVID-19´ s pandemic, post-COVID-19 condition
represents a post-viral syndrome of unprecedented dimensions. SARS-CoV-2, in line with …

Social isolation and control owing to coronavirus disease 2019 (COVID-19) are easing;
however, concerns regarding new infectious diseases have not disappeared. Given …

Endothelial cells are a preferential target for SARS-CoV-2 infection. Previously, we have
reported that vascular adenosine deaminase 1 (ADA1) may serve as a biomarker of …

The pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
has had a profound impact on the global health and economy. While mass vaccination for …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is persistently
threatening the lives of thousands of individuals globally. It triggers pulmonary oedema …